Skip to main content
PMC home page
Gut logoLink to Gut
. 1980 Jul;21(7):619–623. doi: 10.1136/gut.21.7.619

A new bioassay of VIP: results in watery diarrhoea syndrome.

M C Laburthe, C M Dupont, J D Besson, M Rousset, G E Rosselin
PMCID: PMC1419890  PMID: 7429326

Abstract

Cyclic AMP accumulation in human colon adenocarcinoma cells in culture (HT-29) is known to be particularly sensitive to the stimulating action of vasoactive intestinal peptide (VIP). This property was exploited as a means of investigating the possible role of VIP as a humoral mediator in the watery diarrhoea syndrome. Our results showed that plasma from two patients with watery diarrhoea syndrome associated with ganglioneuroblastoma and pheochromocytoma strongly stimulated cyclic AMP accumulation in HT-29 cells, whereas plasma from normal subjects and patients with other diarrhoeal disorders had no effect. The stimulation induced by serial dilutions of plasma from patients paralleled the VIP-induced response. Preincubation of these plasmas with specific anti-VIP antibody prevented their stimulatory effects. Plasma sampled after the arrest of diarrhoea (spontaneous or after surgical resection of tumours) elicited AMP rise in HT-29 cells. Tumour extract stimulated cyclic AMP accumulation in HT-29 cells with a dose-response curve which was superimposable on the one obtained with standard VIP. The results lend support to the hypothesis that VIP is a humoral mediator in WDS and suggest that the diarrhoea is mediated through a VIP-induced accumulation of cyclic AMP in intestinal epithelial cells.

Full text

PDF
621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amiranoff B., Laburthe M., Dupont C., Rosselin G. Characterization of a vasoactive intestinal peptide-sensitive adenylate cyclase in rat intestinal epithelial cell membranes. Biochim Biophys Acta. 1978 Dec 18;544(3):474–481. doi: 10.1016/0304-4165(78)90321-5. [DOI] [PubMed] [Google Scholar]
  2. Barbezat G. O., Grossman M. I. Intestinal secretion: stimulation by peptides. Science. 1971 Oct 22;174(4007):422–424. doi: 10.1126/science.174.4007.422. [DOI] [PubMed] [Google Scholar]
  3. Besson J., Laburthe M., Bataille D., Dupont C., Rosselin G. Vasoactive intestinal peptide (VIP): tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay. Acta Endocrinol (Copenh) 1978 Apr;87(4):799–810. doi: 10.1530/acta.0.0870799. [DOI] [PubMed] [Google Scholar]
  4. Besson J., Rotsztejn W., Laburthe M., Epelbaum J., Beaudet A., Kordon C., Rosselin G. Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res. 1979 Apr 6;165(1):79–85. doi: 10.1016/0006-8993(79)90046-5. [DOI] [PubMed] [Google Scholar]
  5. Bloom S. R., Polak J. M., Pearse A. G. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet. 1973 Jul 7;2(7819):14–16. doi: 10.1016/s0140-6736(73)91947-8. [DOI] [PubMed] [Google Scholar]
  6. Dupont C., Laburthe M., Broyart J. P., Bataille D., Rosselin G. Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine. Eur J Clin Invest. 1980 Feb;10(1):67–76. doi: 10.1111/j.1365-2362.1980.tb00012.x. [DOI] [PubMed] [Google Scholar]
  7. Field M. Intestinal secretion. Gastroenterology. 1974 May;66(5):1063–1084. [PubMed] [Google Scholar]
  8. Gardner J. D. Plasma VIP in patients with watery diarrhea syndrome. Am J Dig Dis. 1978 Apr;23(4):370–373. doi: 10.1007/BF01072424. [DOI] [PubMed] [Google Scholar]
  9. Jaffe B. M., Condon S. Prostaglandins E and F in endocrine diarrheagenic syndromes. Ann Surg. 1976 Oct;184(4):516–524. doi: 10.1097/00000658-197610000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jaffe B. M. To be or not to VIP. Gastroenterology. 1979 Feb;76(2):417–420. [PubMed] [Google Scholar]
  11. Krejs G. J., Barkley R. M., Read N. W., Fordtran J. S. Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo. J Clin Invest. 1978 May;61(5):1337–1345. doi: 10.1172/JCI109051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laburthe M., Bataille D., Rosselin G. Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay. Acta Endocrinol (Copenh) 1977 Mar;84(3):588–599. doi: 10.1530/acta.0.0840588. [DOI] [PubMed] [Google Scholar]
  13. Laburthe M., Besson J., Bon Hoa D. H., Rosselin G. Récepteurs du peptide intestinal vasoactif (VIP) dans les entérocytes: liaison spécifique et stimulation de l'AMP cyclique. C R Acad Sci Hebd Seances Acad Sci D. 1977 Jun 6;284(21):2139–2142. [PubMed] [Google Scholar]
  14. Laburthe M., Prieto J. C., Amiranoff B., Dupont C., Hui Bon Hoa D., Rosselin G. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate. Eur J Biochem. 1979 May 15;96(2):239–248. doi: 10.1111/j.1432-1033.1979.tb13034.x. [DOI] [PubMed] [Google Scholar]
  15. Laburthe M., Rousset M., Boissard C., Chevalier G., Zweibaum A., Rosselin G. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2772–2775. doi: 10.1073/pnas.75.6.2772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Modlin I. M., Bloom S. R., Mitchell S. J. Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome. Gastroenterology. 1978 Dec;75(6):1051–1054. [PubMed] [Google Scholar]
  17. Polak J. M., Pearse A. G., Garaud J. C., Bloom S. R. Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract. Gut. 1974 Sep;15(9):720–724. doi: 10.1136/gut.15.9.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prieto J. C., Laburthe M., Rosselin G. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites. Eur J Biochem. 1979 May 15;96(2):229–237. doi: 10.1111/j.1432-1033.1979.tb13033.x. [DOI] [PubMed] [Google Scholar]
  19. Said S. I., Faloona G. R. Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N Engl J Med. 1975 Jul 24;293(4):155–160. doi: 10.1056/NEJM197507242930401. [DOI] [PubMed] [Google Scholar]
  20. Sanzenbacher L. J., Mekhjian H. S., King D. R., Zollinger R. M. Studies on the potential role of secretin in the islet cell tumor diarrheogenic syndrome. Ann Surg. 1972 Sep;176(3):394–402. doi: 10.1097/00000658-197209000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Straus E. Radioimmunoassay of gastrointestinal hormones. Gastroenterology. 1978 Jan;74(1):141–152. [PubMed] [Google Scholar]
  22. Strewler G. J., Orloff J. Role of cyclic nucleotides in the transport of water and electrolytes. Adv Cyclic Nucleotide Res. 1977;8:311–361. [PubMed] [Google Scholar]
  23. VERNER J. V., MORRISON A. B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958 Sep;25(3):374–380. doi: 10.1016/0002-9343(58)90075-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES